Ropinirole ruled out by EXPERTS-ALS drug-screening platform
A second interim analysis from EXPERTS-ALS finds that ropinirole did [...]
Multimillion-pound partnership breaks down barriers in MND research
Motor neuron disease (MND) is one of the most complex [...]
Metformin and nifedipine ruled out by EXPERTS-ALS drug-screening platform
An interim result from the EXPERTS-ALS trial shows neither drug [...]
Apathy in MND may reflect how much harder daily tasks have become, not a loss of motivation
A University of Sheffield study, supported by people who took [...]
Exploring the first wave of drugs entering our innovative EXPERTS-ALS platform
Six people are diagnosed with motor neuron disease (MND) in [...]
New study identifies a genetic cause of MND in one in four people with the condition
A major international study has found that one in four [...]
New drug smilagenin to be evaluated through EXPERTS-ALS platform
A new candidate treatment for motor neuron disease (MND) will [...]
Neflamapimod to be evaluated through EXPERTS-ALS platform
A potential new treatment for motor neuron disease (MND) will [...]
Our first three years: what we’ve achieved together so far
As we enter the next phase of funding, it’s important to look [...]
UK MND RI biomarkers research programme reaches recruitment target
The UK MND RI’s biosampling platform has now recruited 212 [...]
